ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,367, issued on Sept. 15, was assigned to University of Washington (Seattle).

"Techniques for predicting and treating refractory ventricular fibrillation" was invented by Jason Coult (Seattle), Thomas Rea (Seattle), Peter J. Kudenchuk (Seattle), Heemun Kwok (Seattle) and Jose Nathan Kutz (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "An example method includes identifying a first segment of an electrocardiogram (ECG) that ends prior to administration of an electrical shock and identifying at least one second segment of the ECG that begins after the administration of the electrical shock. The example method further includes predicting, based...